Keywords:
5-(p-asetilamidofenil)-1,3,4-oksadiazol-2-tion, kam zaharli, dofaminomimetik, psixo-farmakologik faollik, sedativ faollik, persen.References
1. Indrakumar Subramanian, Remya Ramachandran Surajambika, Dibenthiran Sekar, Ramalakshmi Natarajan and Nalini Calamur Nagarajan. A Systematic Review on Isoquinoline Derivatives as Emerging Multi-target Agents in Alzheimer's and Parkinson's Disorder Therapy. Central Nervous System Agents in Medicinal Chemistry, 19 March 2026, https://doi.org/10.2174/0118715249401454260108062419
2. Boström J., Hogner A., Llinàs A., Wellner E., Plowright A. T. Oxadiazolesin medicinal chemistry. // J. Med. Chem. – 2012. – Vol. 55. – P. 1817–1830.
3. Othman A.A., Kihel M., Amara S. 1,3,4-Oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole derivatives as potential antibacterial agents. // Arabian J. Chem. 2014, http://dx.doi.org/10.1016/j.arabic. 2014. 09.003.
4. Ziyaev A.A., Ismailova D.S. Biological activity of 5-(2,3,4-pyridyl)-1,3,4-oxadiazol-2-thiones and their derivatives. //World J. Pharm. Research. –2017. – Vol. 6. – №. 4. – P. 52–77.
5. Nagaraj Chaluvaraju K.C., Niranjan M.S., Kiran S. 1,3,4-Oxadiazole: A potent drug candidate with various pharmacological activities. // Inter. J.Pharm. Pharm. Scien. – 2011. – №. 3. – P. 9 –16.
6. Gollapalli N.R., Kavuri N.S., Kumba P. et all. Recent advance in analgesic and antiinflammatory activity of oxadiazole derivatives// Asian J. Pharm. Anal. Med. Chem. – 2015. – Vol. 3. – №1. – P. 20–30.
7. Kharb R., Kaur R., Sharma A.K. Vistas on antimicrobial potential of noveloxadiazole derivatives in modern medicinal chemistry // Euro. J. Biomed. Pharm. Scien. –2014. – Vol. 1. – №. 2. – P. 401– 420.
8. Arshad M. 1,3,4-oxadiazole nucleus with versatile pharmacological applications: A review // Inter. J. Parm. Scien. Research. – 2014. –Vol. 5. –№. 4. – P. 1124–1137.
9. Dholaria P., Parikh K., Joshi D. Synthetic and therapeutic journey of 1,3,4-oxadiazoles: A review // Inter. J. Chem. Appl. – 2015. – Vol. 4. – P. 1–25.
10. Oliveira C.S., Lira B.F., Barbosa-Filho J.M., Fernandez-Lorenzo J.G., Athayde-Filho P.F. Synthetic approaches and pharmacological activity of 1,3,4-oxadiazoles: A Review of the literature from 2000 –2012 // Molecules – 2012. – №. 17. – P. 10192–10231.
11. Sharma R., Kumar N., Yaday R. Chemistry and Pharmacological Importance of 1,3,4-Oxadiazole Derivative Research & Reviews // J. Chem. –2015. – Vol. 4. – P. 1–27.
12. Salahuddin, Mazumder A., Yar M.S., Mazumder R., Chakraborthy G.S., Ahsan M.J., Rahman M.U. Updates on synthesis and biological activities of 1,3,4-oxadiazole: A review. Synth. Commun. 2017; 47:1805–1847. doi: 10.1080/00397911.2017.1360 911.
13. Bajaj S., Asati V., Singh J., Roy P.P. 1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents. Eur. J. Med. Chem. 2015; 97:124–141. doi: 10.1016/ j.ejmech.2015.04.051.
14. Bala S., Saini V., Kamboj S., Prasad D.N. Review Exploring Antiinflammatory Potential of 1,3,4-Oxadiazole Derivatives as Promising Lead. Int. J. Pharm. Sci. Rev. Res. 2012;17:84–89.
15. Khalilullah H.J., Ahsan M., Hedaitullah M., Khan S., Ahmed B. 1,3,4-Oxadiazole: A Biologically Active Scaffold. Mini-Rev. Med. Chem. 2012;12:789–801. doi: 10.2174/138955712801264800.
16. Bajaj S., Roy P.P., Singh J. 1,3,4-Oxadiazoles as Telomerase Inhibitor: Potential Anticancer Agents. Anti-Cancer Agents Med. Chem. 2018; 17:18 69–1883. doi: 10.2174/1871521409666170425092 906.
17. Rashidov S.Z., Rakhimboev S.D., Sanoev Z.I., Abdinazarov I.T., Khamroev T.T., Ismailova D.S., & Elmuradov B.J. (2022). Study of psychoactive activity potassium salt 5-(o-aminophenyl)-1,3,4- oxadiazole-2-thion (d-361). International Journal of Medical Sciences and Clinical Research, 2(09), 1–5.
18. Sanoev Z. I, Rashidov S. Z. O, Khamroev T. T, Abdinazarov I. T, Rakhimboev S. D. O, Ismailova D. S, Elmuradov B. Z, Shakhmurova M. A. K. Synthesis and Antidepressant Activity of 5-(2-Aminophenyl)-1,3,4-Oxadiazole-2-(3H)-Thione. Biomed Pharmacol J 2026; 19(1). p. 642-652 https://dx.doi.org/10.130 05/bpj/3381
19. Sultanov S. A., Sanoyev Z. I., Sirov V. N., Ismailova D. S., Elmuradov B. J., Pharmacological and Toxicological Evaluation of 5-(p-Aminophenyl)-1,3,4-oxadiazole-2-thione Potassium Salt: Acute Toxicity and Anxiolytic Activity in Experimental Models, American Journal of Medicine and Medical Sciences, Vol. 16 No. 5, 2026, pp. 2287-2292. doi: 10.5923 /j.ajmms.20261605.14.
20. Миронов А.Н. Руководство по проведению доклинических исследований лекарственных средств. Часть первая. – М.: Гриф и К, 2012. -944 с.
21. Strelkov R.B. Statistical data for accelerated quantitative assessment of pharmacological effect. Pharmacology and Toxicology 1986. No. 4 p.100-104.
22. Wąsik A, Polak D, Romańska I, Michaluk J, Antkiewicz-Michaluk L. The impact of 1MeTIQ on the dopaminergic system function in the 6-OHDA model of Parkinson's disease. Pharmacol Rep. 2016 Dec;68(6):1205-1213. doi: 10.1016/j.pharep.2016. 08.004. Epub 2016 Aug 13. PMID: 27657483.
